XML 66 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Summary of assets and liabilities recorded at fair value
The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:
As of September 30, 2016 (In millions)
Total
 
Quoted Prices
in Active
Markets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
1,736.4

 
$

 
$
1,736.4

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
2,632.1

 

 
2,632.1

 

Government securities
2,038.2

 

 
2,038.2

 

Mortgage and other asset backed securities
657.8

 

 
657.8

 

Marketable equity securities
29.0

 
29.0

 

 

Derivative contracts
20.3

 

 
20.3

 

Plan assets for deferred compensation
34.1

 

 
34.1

 

Total
$
7,147.9

 
$
29.0

 
$
7,118.9

 
$

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
14.0

 
$

 
$
14.0

 
$

Contingent consideration obligations
521.6

 

 

 
521.6

Total
$
535.6

 
$

 
$
14.0

 
$
521.6


As of December 31, 2015 (In millions)
Total
 
Quoted Prices
in Active
Markets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
909.5

 
$

 
$
909.5

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
1,510.9

 

 
1,510.9

 

Government securities
2,875.9

 

 
2,875.9

 

Mortgage and other asset backed securities
494.1

 

 
494.1

 

Marketable equity securities
37.5

 
37.5

 

 

Derivative contracts
27.2

 

 
27.2

 

Plan assets for deferred compensation
40.1

 

 
40.1

 

Total
$
5,895.2

 
$
37.5

 
$
5,857.7

 
$

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
14.7

 
$

 
$
14.7

 
$

Contingent consideration obligations
506.0

 

 

 
506.0

Total
$
520.7

 
$

 
$
14.7

 
$
506.0

Summary of fair and carrying value of debt instruments
The fair and carrying values of our debt instruments, which are Level 2 liabilities, are summarized as follows:
 
As of September 30, 2016
 
As of December 31, 2015
(In millions)
Fair
Value
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
Notes payable to Fumedica
$
6.5

 
$
6.3

 
$
9.4

 
$
9.0

6.875% Senior Notes due March 1, 2018
591.9

 
560.2

 
602.6

 
565.3

2.900% Senior Notes due September 15, 2020
1,558.1

 
1,500.6

 
1,497.5

 
1,485.5

3.625% Senior Notes due September 15, 2022
1,070.8

 
993.0

 
1,014.2

 
992.2

4.050% Senior Notes due September 15, 2025
1,908.3

 
1,734.5

 
1,764.6

 
1,733.4

5.200% Senior Notes due September 15, 2045
2,070.5

 
1,721.4

 
1,757.6

 
1,721.1

Total
$
7,206.1

 
$
6,516.0

 
$
6,645.9

 
$
6,506.5

Fair value of contingent consideration obligations
The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:
 
For the Three Months
Ended September 30,
 
For the Nine Months
Ended September 30,
(In millions)
2016
 
2015
 
2016
 
2015
Fair value, beginning of period
$
515.7

 
$
495.7

 
$
506.0

 
$
215.5

Additions

 

 

 
274.5

Changes in fair value
5.9

 
0.2

 
18.8

 
5.9

Payments

 
(14.5
)
 
(3.2
)
 
(14.5
)
Fair value, end of period
$
521.6

 
$
481.4

 
$
521.6

 
$
481.4